Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Cal Gary who wrote (8186)	12/7/2001 4:14:01 PM
From: Montana Wildhack	Read Replies (1) \| Respond to of 14101

Hi CG, Nice close at 4.65. I need to go through the calculations. I'll have them by tomorrow. Its the right time to ask that question. Wolf

To: Cal Gary who wrote (8186)	12/8/2001 1:53:35 PM
From: Montana Wildhack	Read Replies (2) \| Respond to of 14101

Hi CG, Re: Cash burn rate question With a company this small and no sizable monthly sales, each transaction can have huge impacts in predicting cash positions. For instance the 1/2 million in cash given to OXO in the last reported quarter. I notice the current liabilities jumped by 1446 last quarter and a large move in non-cash working capital. I also suspect some options were exercised in this current quarter (Nov) and predict it was a sizable number. Having said that I use the KISS principle. Unknowns are left out and I use the previous reported numbers as is. From that I get: Cash Aug 31 -219,000 Deficit for quarter - (2,695,000) Non cash amortization - 107,000 Cash from issuance - 1,500,000 Equals net cash Nov 30 - (869,000) So I'm short 869,000 and I think the Sales&Marketing expenses rose in the November quarter. Possible pluses: Dioptic labs sales came back on stream for 250,000+ Exercised options created a small 6 figure cash amount Revenue was received from Provalis Possible negatives: The Cdn sales force expenses The current liabilities had to be paid Further capital asset investments for the plant (I suspect item 2 is related to the plant as well) I'm waiting for the next week or so to see how they pulled this off without a decent chunk from Provalis. For Feb 28 they have just about the right amount of cash from this draw to get through the quarter. Reviewing Rebecca's comments about cash positive by end of Feb makes for an interesting quarter to watch. All in all she has kept the ship going during our delays for beaurocracy with less dilution than the previous year Wolf